Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA)

Leukemia Research

Volumn 34, Issue 10, 2010, Pages 1344-1350

  Koh, Youngil ^a   Lee, Hye Ryun ^a   Song, Eun Young ^a   Kim, Hyun Kyoung ^a   Kim, Inho ^a,b   Park, Seonyang ^a,b   Park, Myoung Hee ^a   Kim, Byoung Kook ^a,b   Yoon, Sung Soo ^a,b   Lee, Dong Soon ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Aplastic anemia; FISH; Hypoplastic myelodysplastic syndrome; Karyotype

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; OXYMETHOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHROMOSOME 20Q; CHROMOSOME DELETION; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HYPOPLASTIC MYELODYSPLASTIC SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SOUTH KOREA; TRISOMY 8;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 77955940725     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.03.001     Document Type: Article

References (26)

1. Wong K.F., So C.C. Hypoplastic myelodysplastic syndrome-a clinical, morphologic, or genetic diagnosis?. Cancer Genet Cytogenet 2002, 138:85-88.
2. Maschek H., Kaloutsi V., Rodriguez-Kaiser M., Werner M., Choritz H., Mainzer K., Dietzfelbinger M., Georgii A. Hypoplastic myelodysplastic syndrome: Incidence, morphology, cytogenetics, and prognosis. Ann Hematol 1993, 66:117-122.
3. Huang T.C., Ko B.S., Tang J.L., Hsu C., Chen C.Y., Tsay W., Huang S.Y., Yao M., Chen Y.C., Shen M.C., Wang C.H., Tien H.F. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by international prognostic scoring system, cytogenetic and genetic studies. Leukemia 2008, 22:544-550.
4. Yue G., Hao S., Fadare O., Baker S., Pozdnyakova O., Galili N., Woda B.A., Raza A., Wang S.A. Hypocellularity in myelodysplastic syndrome is an independent factor, which predicts a favorable outcome. Leuk Res 2008, 32:553-558.
5. Young N.S. Acquired aplastic anemia. Ann Intern Med 2002, 136:534-546.
6. Young N.S., Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med 1997, 336:1365-1372.
7. Bennett J.M., Orazi A. Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach. Haematologica 2009, 94:264-268.
8. Aivado M., Rong A., Stadler M., Germing U., Giagounidis A., Strupp C., Novotny J., Josten K.M., Kobbe G., Hildebrandt B., Gattermann N., Aul C., Haas R., Ganser A. Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of x-chromosome inactivation in bone marrow cells. Eur J Haematol 2002, 68:210-216.
9. Tichelli A., Gratwohl A., Wuersch A., Nissen C., Speck B. Antilymphocyte globulin for myelodysplastic syndrome. Br J Haematol 1988, 68:139-140.
10. Jonasova A., Neuwirtova R., Cermak J., Vozobulova V., Mocikova K., Siskova M., Hochova I. Cyclosporin a therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998, 100:304-309.
11. Yazji S., Giles F.J., Tsimberidou A.M., Estey E.H., Kantarjian H.M., O'Brien S.A., Kurzrock R. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes. Leukemia 2003, 17:2101-2106.
12. Sloand E.M. Hypocellular myelodysplasia. Hematol Oncol Clin North Am 2009, 23:347-360.
13. Garg R., Faderl S., Garcia-Manero G., Cortes J., Koller C., Huang X., York S., Pierce S., Brandt M., Beran M., Borthakur G., Kantarjian H., Ravandi F. Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome. Leukemia 2009, 23:1297-1302.
14. Keung Y.K., Pettenati M.J., Cruz J.M., Powell B.L., Woodruff R.D., Buss D.H. Bone marrow cytogenetic abnormalities of aplastic anemia. Am J Hematol 2001, 66:167-171.
15. Appelbaum F.R., Barrall J., Storb R., Ramberg R., Doney K., Sale G.E., Thomas E.D. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol 1987, 15:1134-1139.
16. Gupta V., Brooker C., Tooze J.A., Yi Q.L., Sage D., Turner D., Kangasabapathy P., Marsh J.C. Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults. Br J Haematol 2006, 134:95-99.
17. Bottiger L.E. Epidemiology and aetiology of aplastic anemia. Haematol Blood Transfus 1979, 24:27-37.
18. International Agranulocytosis Aplastic Anemia Study Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood 1987, 70:1718-1721.
19. Rozman C., Marin P., Nomdedeu B., Montserrat E. Criteria for severe aplastic anaemia. Lancet 1987, 2:955-957.
20. Young N.S. Aplastic anaemia. Lancet 1995, 346:228-232.
21. WHO classification of tumors of hematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer (IARC), Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
22. Rosenfeld S., Follmann D., Nunez O., Young N.S. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003, 289:1130-1135.
23. Rooney D., Czepalkowski B. Human cytogenetics, a practical approach 1992, Oxford University Press, New York.
24. Mitelman I.F. ISCN: an international system for human cytogenetic nomenclature 1995, S. Karger, Basel.
25. Ohara A., Kojima S., Hamajima N., Tsuchida M., Imashuku S., Ohta S., Sasaki H., Okamura J., Sugita K., Kigasawa H., Kiriyama Y., Akatsuka J., Tsukimoto I. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 1997, 90:1009-1013.
26. Park H.-K., Lee D.S., Lee H.R., Cho H.I., Kim H.K., Yoon S.-S., Kim B.K. Gain of 1q as a potential candidate for an adverse prognostic marker in myelodysplastic syndrome: comparison with international prognostic scoring system variables. Blood 2008, 112. [ASH Meeting Abstracts].